SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-007835
Filing Date
2012-02-10
Accepted
2012-02-10 16:52:22
Documents
1
Period of Report
2012-02-08

Document Format Files

Seq Description Document Type Size
1 ANNUAL EQUITY COMPENSATION rrd333745.html 4  
1 ANNUAL EQUITY COMPENSATION rrd333745.xml 4 6694
  Complete submission text file 0001181431-12-007835.txt   8284
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEKTAR THERAPEUTICS 201 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address
Nicholson John (Reporting) CIK: 0001420766 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24006 | Film No.: 12593691